论文部分内容阅读
1993年10月～1997年1月，用EMA／CO方案联合化疗治疗妊娠恶性滋养细胞肿瘤（GTT）26例，总结其疗效和毒副作用。在可评价疗效的22例中，近期治愈21例，治愈率95．5％，恶性葡萄胎（恶葡）治愈率100％，绒癌治愈率90．0％。生存期2～39个月，中位生存期16个月。本组毒副作用主要为胃肠道反应、脱发及白细胞下降，毒性范围多在Ⅰ～Ⅱ度，均可耐受，停药后即可恢复正常。作者认为：EMA／CO方案疗效高，见效快，毒性小，可用于治疗各期滋养细胞肿瘤，尤其适用于重症及耐药患者。
From October 1993 to January 1997, 26 cases of pregnancy-induced gestational trophoblastic tumor (GTT) were treated with EMA / CO regimen combined with chemotherapy, and the curative effect and side effects were summarized. Among the 22 evaluable curative effects, 21 cases were cured in the near future, with a cure rate of 95.5%. The cure rate of malignant mole (ECP) was 100% and the cure rate of choriocarcinoma was 90.0%. Survival of 2 to 39 months, the median survival of 16 months. The main side effects of this group of gastrointestinal reactions, hair loss and leukopenia, toxicity in the range of Ⅰ ~ Ⅱ degrees, can be tolerated, to resume normal after withdrawal. The authors believe: EMA / CO program efficacy, quick, low toxicity, can be used to treat various stages of trophoblastic tumors, especially for patients with severe and resistant.